Graham E. Jones

1.3k total citations
21 papers, 700 citations indexed

About

Graham E. Jones is a scholar working on Organic Chemistry, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Graham E. Jones has authored 21 papers receiving a total of 700 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Organic Chemistry, 11 papers in Molecular Biology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Graham E. Jones's work include Chemical synthesis and alkaloids (4 papers), Phenothiazines and Benzothiazines Synthesis and Activities (3 papers) and Catalytic C–H Functionalization Methods (2 papers). Graham E. Jones is often cited by papers focused on Chemical synthesis and alkaloids (4 papers), Phenothiazines and Benzothiazines Synthesis and Activities (3 papers) and Catalytic C–H Functionalization Methods (2 papers). Graham E. Jones collaborates with scholars based in United Kingdom, United States and Switzerland. Graham E. Jones's co-authors include Andrew B. Holmes, Christopher Moore, Hans Rudolf Brenner, Said Hashemolhosseini, Ian T. Forbes, Graeme J. Stewart, Geoffrey Stemp, G.J. BURRELL, John Evans and Gordon S. Baxter and has published in prestigious journals such as Journal of Neuroscience, The Journal of Cell Biology and Oncogene.

In The Last Decade

Graham E. Jones

21 papers receiving 673 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Graham E. Jones United Kingdom	15	418	221	188	80	55	21	700
Marion Lanier United States	16	646 1.5×	272 1.2×	51 0.3×	75 0.9×	27 0.5×	36	986
Corinne E. Augelli‐Szafran United States	21	599 1.4×	221 1.0×	175 0.9×	120 1.5×	81 1.5×	62	1.1k
Patrice Talaga Belgium	14	405 1.0×	216 1.0×	267 1.4×	23 0.3×	71 1.3×	26	924
Helmut Mack Germany	16	533 1.3×	280 1.3×	329 1.8×	112 1.4×	68 1.2×	23	1.1k
María Dolores Pérez‐Carrión Spain	17	283 0.7×	181 0.8×	110 0.6×	91 1.1×	26 0.5×	22	716
Massimo Castorina Italy	18	470 1.1×	400 1.8×	69 0.4×	26 0.3×	70 1.3×	22	935
Marjo Pihlavisto Finland	17	591 1.4×	59 0.3×	202 1.1×	119 1.5×	22 0.4×	28	786
Bruce J. Melancon United States	15	1.1k 2.7×	210 1.0×	371 2.0×	57 0.7×	89 1.6×	36	1.4k
David C. Butler United States	18	730 1.7×	314 1.4×	165 0.9×	91 1.1×	13 0.2×	28	1.3k
Shailendra K. Sahu United States	19	379 0.9×	47 0.2×	98 0.5×	45 0.6×	25 0.5×	40	853

Countries citing papers authored by Graham E. Jones

Since Specialization

Citations

This map shows the geographic impact of Graham E. Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Graham E. Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Graham E. Jones more than expected).

Fields of papers citing papers by Graham E. Jones

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Graham E. Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Graham E. Jones. The network helps show where Graham E. Jones may publish in the future.

Co-authorship network of co-authors of Graham E. Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Graham E. Jones. A scholar is included among the top collaborators of Graham E. Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Graham E. Jones. Graham E. Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Miles, Timothy J., Alan J. Hennessy, B.D. Bax, et al.. (2016). Novel tricyclics (e.g., GSK945237) as potent inhibitors of bacterial type IIA topoisomerases. Bioorganic & Medicinal Chemistry Letters. 26(10). 2464–2469. 33 indexed citations

Jones, Graham E., et al.. (2014). Safer, Greener, and More Facile Alternatives for Synthesis with Organic Azides. Current Organic Synthesis. 11(5). 732–750. 8 indexed citations

Miles, Timothy J., Gerald Brooks, Pamela Brown, et al.. (2011). Novel cyclohexyl-amides as potent antibacterials targeting bacterial type IIA topoisomerases. Bioorganic & Medicinal Chemistry Letters. 21(24). 7483–7488. 33 indexed citations

Stewart, Graeme J., et al.. (2010). A role for the atopy‐associated gene PHF11 in T‐cell activation and viability. Immunology and Cell Biology. 88(8). 817–824. 23 indexed citations

Brooks, Gerald, Pamela Brown, Steven Dabbs, et al.. (2010). Flexible palladium-catalysed amidation reactions for the synthesis of complex aryl amides. Tetrahedron Letters. 51(20). 2685–2689. 20 indexed citations

Brooks, Gerald, Steven Dabbs, David T. Davies, et al.. (2010). The design of efficient and selective routes to pyridyl analogues of 3-oxo-3,4-dihydro-2H-1,4-(benzothiazine or benzoxazine)-6-carbaldehydes. Tetrahedron Letters. 51(38). 5035–5037. 10 indexed citations

Yang, Ying, et al.. (2004). Phosphorylcholine-Containing Polymers for Use in Cell Encapsulation. Artificial Cells Blood Substitutes and Biotechnology. 32(1). 91–104. 5 indexed citations

Jones, Graham E. & Graeme J. Stewart. (2003). Nuclear import of N-terminal FAK by activation of the FcεRI receptor in RBL-2H3 cells. Biochemical and Biophysical Research Communications. 314(1). 39–45. 21 indexed citations

Labuhn, Martin, Graham E. Jones, Daniel Maier, et al.. (2001). Quantitative real-time PCR does not show selective targeting of p14ARF but concomitant inactivation of both p16INK4A and p14ARF in 105 human primary gliomas. Oncogene. 20(9). 1103–1109. 50 indexed citations

10.

Bromidge, Steven M., Steven Dabbs, Susannah Davies, et al.. (2000). 1-[2-[(Heteroaryloxy)heteroaryl]carbamoyl]indolines: novel and selective 5-HT2C receptor inverse agonists with potential as antidepressant/Anxiolytic agents. Bioorganic & Medicinal Chemistry Letters. 10(16). 1863–1866. 16 indexed citations

11.

Bromidge, Steven M., Susannah Davies, D. Malcolm Duckworth, et al.. (2000). 1-[2-[(Heteroarylmethoxy)aryl]carbamoyl]indolines are selective and orally active 5-HT2C receptor inverse agonists. Bioorganic & Medicinal Chemistry Letters. 10(16). 1867–1870. 10 indexed citations

12.

Bromidge, Steven M., Steven Dabbs, David T. Davies, et al.. (1999). Model studies on a synthetically facile series of N-substituted phenyl-N′-pyridin-3-yl ureas leading to 1-(3-pyridylcarbamoyl) indolines that are potent and selective 5-HT2C/2B receptor antagonists. Bioorganic & Medicinal Chemistry. 7(12). 2767–2773. 5 indexed citations

13.

Jones, Graham E., Christopher Moore, Said Hashemolhosseini, & Hans Rudolf Brenner. (1999). Constitutively Active MuSK Is Clustered in the Absence of Agrin and Induces Ectopic Postsynaptic-Like Membranes in Skeletal Muscle Fibers. Journal of Neuroscience. 19(9). 3376–3383. 89 indexed citations

14.

Bromidge, Steven M., Steven Dabbs, David T. Davies, et al.. (1998). Novel and Selective 5-HT_2C/2B Receptor Antagonists as Potential Anxiolytic Agents: Synthesis, Quantitative Structure−Activity Relationships, and Molecular Modeling of Substituted 1-(3-Pyridylcarbamoyl)indolines. Journal of Medicinal Chemistry. 41(10). 1598–1612. 53 indexed citations

15.

Meier, Thomas, Christopher Moore, Fabrice Schoumacher, et al.. (1998). Agrin Can Mediate Acetylcholine Receptor Gene Expression in Muscle by Aggregation of Muscle-derived Neuregulins. The Journal of Cell Biology. 141(3). 715–726. 99 indexed citations

16.

Forbes, Ian T., Steven Dabbs, D. Malcolm Duckworth, et al.. (1996). Synthesis, Biological Activity, and Molecular Modeling Studies of Selective 5-HT_2C/2B Receptor Antagonists. Journal of Medicinal Chemistry. 39(25). 4966–4977. 23 indexed citations

17.

Forbes, Ian T., et al.. (1995). N-(1-Methyl-5-indolyl)-N'-(3-methyl-5-isothiazolyl)urea: A Novel, High-Affinity 5-HT2B Receptor Antagonist. Journal of Medicinal Chemistry. 38(6). 855–857. 62 indexed citations

18.

BURRELL, G.J., John Evans, Graham E. Jones, & Geoffrey Stemp. (1990). The action of diethylaminosulphur trifluoride (dast) on trans-4-amido- 3-Chromanols: Preparation of cis-amidoalcohols via oxazolines. Tetrahedron Letters. 31(25). 3649–3652. 61 indexed citations

19.

Jones, Graham E. & Andrew B. Holmes. (1982). Acylation reactions of silylated butadiynes: synthesis of some naturally occuring diacetylenic ketones. Tetrahedron Letters. 23(31). 3203–3206. 15 indexed citations

20.

Holmes, Andrew B. & Graham E. Jones. (1980). Synthesis of 4-alkyl-1-trimethylsilylbuta-1,3-diynes. Tetrahedron Letters. 21(32). 3111–3112. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact